Surface CD152 (CTLA-4) Expression and Signaling Dictates Longevity of CD28null T Cells
- 1 May 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 182 (9) , 5342-5351
Abstract
CD28null T cells are a highly enriched subset of proinflammatory T cells in patients with autoimmune diseases that are oligoclonal and autoreactive. In this study, we analyzed the role of CD152 signaling on the longevity of human CD28null T cells. Using a sensitive staining method for CD152, we show that human CD4+CD28null and CD8+CD28null T cells rapidly express surface CD152. Serological inactivation of CD152 using specific Fab or blockade of CD152 ligands using CTLA-4Ig in CD4+CD28null and CD8+CD28null T cells enhances apoptosis in a Fas/FasL-dependent manner. CD152 cross-linking on activated CD28null cells prevents activation-induced cell death as a result of reduced caspase activity. Apoptosis protection conferred by CD152 is mediated by phosphatidylinositol 3′-kinase-dependent activation of the kinase Akt, resulting in enhanced phosphorylation and thereby inhibition of the proapoptotic molecule Bad. We show that signals triggered by CD152 act directly on activated CD28null T lymphocytes and, due to its exclusive expression as a receptor for CD80/CD86 on CD28null T cells, prevention of CD152-mediated signaling is likely a target mechanism taking place during therapy with CTLA-4Ig. Our data imply strongly that antagonistic approaches using CD152 signals for chronic immune responses might be beneficial.Keywords
This publication has 50 references indexed in Scilit:
- Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonistJournal of Clinical Investigation, 2006
- Competition and cooperation: Signal transduction by CD28 and CTLA-4Signal Transduction, 2006
- CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase FunctionJournal of Experimental Medicine, 2004
- Molecular Basis for the Loss of CD28 Expression in Senescent T CellsJournal of Biological Chemistry, 2002
- Proliferative arrest and cell cycle regulation in CD8+CD28− versus CD8+CD28+ T cellsHuman Immunology, 2002
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- Age-Related Persistent Clonal Expansions of CD28−Cells: Phenotypic and Molecular TCR Analysis Reveals both CD4+and CD4+CD8+Cells with Identical CDR3 SequencesClinical Immunology and Immunopathology, 1998
- RETRACTED: The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign AntigensImmunity, 1998
- Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR EngagementImmunity, 1996
- Phenotypic and functional characteristics of activated CD8+ cells: A CD11b−CD28− subset mediates noncytolytic functional suppressionClinical Immunology and Immunopathology, 1991